This strain contains 12 protein-level mutations:
We identified all possible linear viral peptides affected by these mutations. Whenever it was possible, we matched the reference peptide with the mutated one. For example, D -> L mutation transformed SDNGPQNQR to SLNGPQNQR. Cases when it was not meaningful included deletions and insertions at the flanks of the peptide, e.g., HV deletion in NVTWFHAIHV peptide.
Then, we predicted binding affinities between the selected peptides and frequent HLA alleles. Predictions were made with NetMHCpan-4.1 and NetMHCIIpan-4.0. The binding affinities were classifies into three groups:
Here we report HLA-peptide interactions whose affinity was altered by at least two folds. Note that mutations with empty set of altered interactions are not showed.
Weaker binding was not found, while stronger binding was found for 54 entries. There are 10 tight binders for the HLA-DRB1*14:01 in the reference immunopeptidome (IC50 affinity ≤ 50 nM); 0 of them became non-tight binders (0.0%) and 0 novel tight binders appeared (0.0%). To avoid possible divisions by zero, we used + 1 regularization term in denominators when calculating percentages.
Reference MKFLVFLGIITTVAAFHQECSLQSCTQHQPYVV
||||||| |||||||||||||||||||||||||
Mutated MKFLVFLRIITTVAAFHQECSLQSCTQHQPYVV
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-DRB1*14:01 | MKFLVFLGIITTVAAFH | MKFLVFLRIITTVAAFH | 732 | 350 |
HLA-DRB1*14:01 | LVFLGIITTVAAFHQEC | LVFLRIITTVAAFHQEC | 689 | 340 |
HLA-DRB1*14:01 | MKFLVFLGIITTVAA | MKFLVFLRIITTVAA | 707 | 349 |
HLA-DRB1*14:01 | VFLGIITTVAAFHQECS | VFLRIITTVAAFHQECS | 702 | 347 |
HLA-DRB1*14:01 | FLVFLGIITTVAAFHQE | FLVFLRIITTVAAFHQE | 570 | 282 |
HLA-DRB1*14:01 | KFLVFLGIITTVAAFHQ | KFLVFLRIITTVAAFHQ | 555 | 275 |
Reference CVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHF
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated CVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHF
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-DRB1*14:01 | TVFPPTSFGPLVRKI | TVFPLTSFGPLVRKI | 2669 | 333 |
HLA-DRB1*14:01 | STVFPPTSFGPLVRK | STVFPLTSFGPLVRK | 3007 | 392 |
HLA-DRB1*14:01 | FSTVFPPTSFGPLVR | FSTVFPLTSFGPLVR | 2885 | 482 |
HLA-DRB1*14:01 | HCANFNVLFSTVFPP | HCANFNVLFSTVFPL | 759 | 186 |
HLA-DRB1*14:01 | STVFPPTSFGPLVRKIF | STVFPLTSFGPLVRKIF | 1597 | 397 |
HLA-DRB1*14:01 | NVLFSTVFPPTSFGPLVRKI | NVLFSTVFPLTSFGPLVRKI | 1585 | 429 |
HLA-DRB1*14:01 | VFPPTSFGPLVRKIF | VFPLTSFGPLVRKIF | 844 | 233 |
HLA-DRB1*14:01 | CANFNVLFSTVFPPT | CANFNVLFSTVFPLT | 473 | 134 |
HLA-DRB1*14:01 | NVLFSTVFPPTSFGP | NVLFSTVFPLTSFGP | 751 | 216 |
HLA-DRB1*14:01 | ANFNVLFSTVFPPTS | ANFNVLFSTVFPLTS | 386 | 114 |
HLA-DRB1*14:01 | CANFNVLFSTVFPPTS | CANFNVLFSTVFPLTS | 1044 | 314 |
HLA-DRB1*14:01 | HCANFNVLFSTVFPPTS | HCANFNVLFSTVFPLTS | 783 | 248 |
HLA-DRB1*14:01 | HCANFNVLFSTVFPPT | HCANFNVLFSTVFPLT | 1209 | 384 |
HLA-DRB1*14:01 | TVFPPTSFGPLVRKIFV | TVFPLTSFGPLVRKIFV | 1121 | 361 |
HLA-DRB1*14:01 | STVFPPTSFGPLVRKIFVDG | STVFPLTSFGPLVRKIFVDG | 1419 | 457 |
HLA-DRB1*14:01 | VLFSTVFPPTSFGPLVRKIF | VLFSTVFPLTSFGPLVRKIF | 1231 | 412 |
HLA-DRB1*14:01 | FSTVFPPTSFGPLVRKIFVD | FSTVFPLTSFGPLVRKIFVD | 1252 | 420 |
HLA-DRB1*14:01 | LHCANFNVLFSTVFPPT | LHCANFNVLFSTVFPLT | 881 | 306 |
HLA-DRB1*14:01 | NFNVLFSTVFPPTSF | NFNVLFSTVFPLTSF | 330 | 116 |
HLA-DRB1*14:01 | VFPPTSFGPLVRKIFV | VFPLTSFGPLVRKIFV | 1350 | 479 |
HLA-DRB1*14:01 | VFPPTSFGPLVRKIFVD | VFPLTSFGPLVRKIFVD | 1204 | 429 |
HLA-DRB1*14:01 | LFSTVFPPTSFGPLVRKIFV | LFSTVFPLTSFGPLVRKIFV | 1094 | 396 |
HLA-DRB1*14:01 | NFNVLFSTVFPPTSFGP | NFNVLFSTVFPLTSFGP | 728 | 273 |
HLA-DRB1*14:01 | FNVLFSTVFPPTSFG | FNVLFSTVFPLTSFG | 432 | 165 |
HLA-DRB1*14:01 | ILHCANFNVLFSTVFPP | ILHCANFNVLFSTVFPL | 1057 | 411 |
HLA-DRB1*14:01 | FNVLFSTVFPPTSFGPLVRK | FNVLFSTVFPLTSFGPLVRK | 1186 | 467 |
HLA-DRB1*14:01 | ANFNVLFSTVFPPTSFG | ANFNVLFSTVFPLTSFG | 653 | 258 |
HLA-DRB1*14:01 | FPPTSFGPLVRKIFV | FPLTSFGPLVRKIFV | 608 | 242 |
HLA-DRB1*14:01 | CANFNVLFSTVFPPTSF | CANFNVLFSTVFPLTSF | 618 | 247 |
HLA-DRB1*14:01 | NFNVLFSTVFPPTSFG | NFNVLFSTVFPLTSFG | 900 | 360 |
HLA-DRB1*14:01 | TVFPPTSFGPLVRKIFVDGV | TVFPLTSFGPLVRKIFVDGV | 1160 | 465 |
HLA-DRB1*14:01 | ANFNVLFSTVFPPTSF | ANFNVLFSTVFPLTSF | 812 | 327 |
HLA-DRB1*14:01 | FNVLFSTVFPPTSFGPL | FNVLFSTVFPLTSFGPL | 944 | 381 |
HLA-DRB1*14:01 | VLFSTVFPPTSFGPL | VLFSTVFPLTSFGPL | 1226 | 495 |
HLA-DRB1*14:01 | ILHCANFNVLFSTVFPPTS | ILHCANFNVLFSTVFPLTS | 1031 | 445 |
HLA-DRB1*14:01 | NFNVLFSTVFPPTSFGPLVR | NFNVLFSTVFPLTSFGPLVR | 976 | 448 |
HLA-DRB1*14:01 | PPTSFGPLVRKIFVD | PLTSFGPLVRKIFVD | 772 | 355 |
Reference LHPTQAPTHLSVDTKFKTEGLCVDIPGIPKDMTYRRLISMMGFKMNYQVNG
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated LHPTQAPTHLSVDTKFKTEGLCVDILGIPKDMTYRRLISMMGFKMNYQVNG
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-DRB1*14:01 | VDIPGIPKDMTYRRL | VDILGIPKDMTYRRL | 3537 | 475 |
Reference ALLADKFPVLHDIGNPKAIKCVPQADVEWKFYDAQPCSDKAYKIEELFYSY
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated ALLADKFPVLHDIGNPKAIKCVPQAYVEWKFYDAQPCSDKAYKIEELFYSY
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-DRB1*14:01 | IGNPKAIKCVPQADV | IGNPKAIKCVPQAYV | 1272 | 478 |
HLA-DRB1*14:01 | HDIGNPKAIKCVPQADVEWK | HDIGNPKAIKCVPQAYVEWK | 1235 | 475 |
HLA-DRB1*14:01 | NPKAIKCVPQADVEWKFYDA | NPKAIKCVPQAYVEWKFYDA | 1273 | 492 |
HLA-DRB1*14:01 | DIGNPKAIKCVPQADVEWKF | DIGNPKAIKCVPQAYVEWKF | 1187 | 463 |
HLA-DRB1*14:01 | GNPKAIKCVPQADVEWKFYD | GNPKAIKCVPQAYVEWKFYD | 1208 | 481 |
HLA-DRB1*14:01 | GNPKAIKCVPQADVE | GNPKAIKCVPQAYVE | 1054 | 426 |
HLA-DRB1*14:01 | IGNPKAIKCVPQADVEWKFY | IGNPKAIKCVPQAYVEWKFY | 1154 | 468 |
HLA-DRB1*14:01 | KAIKCVPQADVEWKF | KAIKCVPQAYVEWKF | 773 | 316 |
HLA-DRB1*14:01 | NPKAIKCVPQADVEW | NPKAIKCVPQAYVEW | 826 | 348 |
HLA-DRB1*14:01 | PKAIKCVPQADVEWK | PKAIKCVPQAYVEWK | 712 | 307 |